Accelerant (ARX) News
NYSE: ARXFinanceSpecialty InsurersUSD
19.88+0.02 (+0.10%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ARX news summary
We found 9 recent headlines mentioning Accelerant (ARX): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ARX is up 0.10% at $19.88. The most recent story, "Accelerant Announces Third Quarter 2026 Results", was published by Business Wire on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Accelerant headlines
- Accelerant Announces Third Quarter 2026 ResultsATLANTA--(BUSINESS WIRE)--Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today…Business Wire
- Accelerant Q3 Earnings: Will Underwriting Weakness Spoil the Show?ARX faces a projected Q3 earnings drop despite rising premiums and investment income, as weakness in underwriting and MGA Operations clouds the outlook.NasdaqARX, HIG, RNR, MRSH
- American Healthcare REIT (AHR) Q3 FFO Beat EstimatesAmerican Healthcare REIT (AHR) delivered FFO and revenue surprises of +3.57% and -3.92%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqAHR, ARX
- Erie Indemnity (ERIE) Q3 Earnings Surpass EstimatesErie Indemnity (ERIE) delivered earnings and revenue surprises of +2.05% and -2.00%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqERIE, ARX
- Are Finance Stocks Lagging Citigroup (C) This Year?Here is how Citigroup (C) and Accelerant Holdings (ARX) have performed compared to their sector so far this year.NasdaqC, ARX
- Accelerant’s Take-Private Deal Raises a Bigger Question for Insurance StocksAccelerant Holdings (NYSE: ARX) jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech…NasdaqARX, RYAN, KNSL
- Beat the Market the Zacks Way: Accelerant, Insight, General Mills in FocusAccelerant, Shopify and Carpenter Technology delivered strong gains, while Zacks upgrades and model portfolios spotlight key performers.NasdaqBR, MMM, GIS, SJM
- AON's Buybacks Offset Balance Sheet Risks: Is the Stock a Hold?Aon's organic growth, cost savings and strategic acquisitions support earnings, but high debt and interest costs remain key risks for investors.NasdaqAON, ERIE, WTW, ARX
- Ryan Specialty Group (RYAN) Surpasses Q2 Earnings and Revenue EstimatesRyan Specialty (RYAN) delivered earnings and revenue surprises of +21.31% and +4.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqRYAN, ARX